Cargando…
LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
Autores principales: | GUARDIA, CARLOS G, T HUANG, YUH-CHIN, MORRIS, PETER E, G SIMONSON, STEVEN, D SIMMONS, PHILLIP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548960/ http://dx.doi.org/10.1016/j.chest.2022.08.740 |
Ejemplares similares
-
EXTRA-CORPOREAL CARBON DIOXIDE REMOVAL IN COVID-19 ARDS
por: Boparai, Sukhmani, et al.
Publicado: (2020) -
PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021) -
ARDS following oesophagectomy: a comparison of two trials
por: Howells, Phillip A, et al.
Publicado: (2017) -
Deposition of Aerosolized Lucinactant in Nonhuman Primates
por: Gregory, Timothy J., et al.
Publicado: (2020) -
MANAGEMENT OF PNEUMOTHORAX AND PNEUMOMEDIASTINUM IN COVID-19 PATIENTS WITH ARDS
por: BAKER, COLBY M., et al.
Publicado: (2022)